ACCESS Newswire
14 May 2022, 03:07 GMT+10
Investor Call to be held May 18th at 4:30 p.m. Eastern Time
BOHEMIA, NY / ACCESSWIRE / May 13, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it will file a Form 10Q for its financial results for the period ended March 31, 2022, after the market close on Monday, May 16, 2022. The Company will issue a press release reporting its third quarter fiscal year 2022 financial results, before the market opens on May 17, 2022.
The Company will conduct a conference call for all interested parties on Wednesday, May 18, 2022, at 4:30 p.m. Eastern Time to discuss its financial results.
Conference Call Details
To participate in this call, please dial (877) 270-2148 or (412) 902-6510 (international), or listen via a live webcast, which is available on the Company's Investor Relations page at https://www.scientificindustries.com/investor-relations/ or at https://app.webinar.net/KNqP7LEOkda.
A replay of the call will be available through May 25, 2022, at (877) 344-7529 or (412) 317-0088 (international), replay access code: 7889568, or for 30 days at https://www.scientificindustries.com/investor-relations/.
About Scientific Industries, Inc.
Scientific Industries (OTCQB:SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems under the product name Cell Growth Quantifier and Liquid Injection System. Scientific Industries' products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com.
About Scientific Bioprocessing, Inc.
Scientific Bioprocessing, Inc. (SBI) is dedicated to pioneering digitally simplified bioprocessing by providing actionable insights from lab to production floor. With a broad portfolio of state-of-the-art bioprocess sensors and actuators as well as innovative data analytics software, SBI helps scientists and engineers in bioprocessing to monitor and control critical process parameters and product quality attributes. SBI is a subsidiary of Scientific Industries Inc. (SCND-OTCQB) To learn more, visit www.scientificbio.com.
Safe Harbor Statement
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.
Company Contact:
Helena R. Santos
CEO and President
Phone: 631-567-4700
[email protected]
[email protected]
or:
Joe Dorame
Lytham Partners, LLC
Phone: (602)889-9700
[email protected]
SOURCE: Scientific Industries, Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK CITY, New York: New York City's financial markets reacted sharply this week as shares of local banks and real estate investment...
SEATTLE, Washington: U.S. coffee company Starbucks has said it is not planning to sell all of its business in China, even though a...
NEW YORK, New York - U.S. stocks surged on Thursday, with Wall Street's major indexes climbing nearly 1 percent as investor optimism...
NEW YORK, U.S.: Two giants of the early internet job search era—CareerBuilder and Monster—have formally filed for bankruptcy protection,...
LONDON, U.K.: Amazon has once again been rated the worst major UK grocery retailer by its suppliers when it comes to following fair...
LONDON/NEW YORK/CHICAGO: In suburban Chicago, just 15 minutes from O'Hare International Airport, a small customs brokerage quietly...
MADISON, Wisconsin: Tens of millions of residents across the Midwest and East Coast faced dangerously high temperatures over the weekend...
ABU DHABI, 19th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has become the first and only research hospital in the UAE to receive...
ABU DHABI, 17th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...
ABU DHABI,16th May, 2025 (WAM) - Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking...
ABU DHABI, 6th May, 2025 (WAM) -- PureHealth and its subsidiary SEHA have partnered with the number one US children's hospital, Cincinnati...